T2 Biosystems Touts Positive Results From T2Biothreat Panel Study
T2 Biosystems Inc (NASDAQ:TTOO) announced results upon completing the U.S. clinical evaluation for the T2Biothreat Panel. “We believe the T2Biothreat Panel…
T2 Biosystems Advances To The Phase 2 In HHS And The Steven And Alexandra Cohen Foundation’s LymeX Diagnostics Prize
T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that it has advanced to the Phase 2 accelerator in the U.S. Department of
Why Shares Of Chinese Companies Are Trading Lower? Here Are 54 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Kala Pharmaceuticals, Inc. (NASDAQ: KALA) shares gained 130.5% to $9.03 after the company announced FDA acceptance of a IND application for its KPI-012 for the treatment of persistent corneal epithelial defect.
Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 325 companies set new 52-week lows.
T2 Biosystems Has Been Granted U.S. Patent Number 11,519,016 Titled “NMR Methods And Systems For The Rapid Detection Of Bacteria”
https://ppubs.uspto.gov/pubwebapp/external.html?q=(11519016).pn
T2 Biosystems Regains Compliance With Nasdaq’s Minimum Bid Price Rule
T2 Biosystems, Inc. (NASDAQ:TTOO) (the "Company"), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that it received written notice from the NASDAQ
